当前位置:首页 - 行情中心 - 甘李药业(603087) - 财务分析

甘李药业

(603087)

  

流通市值:325.23亿  总市值:348.23亿
流通股本:5.58亿   总股本:5.97亿

甘李药业(603087)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润1.92亿元,每股收益0.33元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益1182813.18万元,未分配利润749760.16万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产1267978.28万元,负债85165.11万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入878,108,964.524,052,146,959.533,047,039,079.242,066,795,642.77
营业总成本682,007,364.823,211,492,206.212,275,937,092.071,515,608,273.35
其他经营收益
营业利润213,766,531.641,183,672,083.35868,653,239.12631,605,004.11
利润总额212,643,078.031,229,805,744.14925,710,035.08691,021,014.97
净利润192,462,041.721,143,583,603.28818,339,617.3603,680,572.48
每股收益
其他综合收益-565,382.71-973,884.42-406,764.76-21,049.12
综合收益总额191,896,659.011,142,609,718.86817,932,852.54603,659,523.36
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计5,402,552,612.55,484,069,139.154,968,496,815.273,966,168,927.34
非流动资产:
非流动资产合计7,277,230,231.427,142,974,167.397,174,260,871.697,911,626,582.45
资产总计12,679,782,843.9212,627,043,306.5412,142,757,686.9611,877,795,509.79
流动负债:
流动负债合计676,525,886.68815,786,801.63690,456,931.84735,070,490.35
非流动负债:
非流动负债合计175,125,205.71182,787,340.68169,908,284.09177,494,307.38
负债合计851,651,092.39998,574,142.31860,365,215.93912,564,797.73
所有者权益(或股东权益):
归属于母公司股东权益合计11,826,155,581.0311,628,469,164.2311,282,392,471.0310,965,230,712.06
股东权益合计11,828,131,751.5311,628,469,164.2311,282,392,471.0310,965,230,712.06
负债和股东权益合计12,679,782,843.9212,627,043,306.5412,142,757,686.9611,877,795,509.79
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,100,469,222.83,984,925,452.832,960,577,867.951,959,456,149.26
经营活动现金流出小计928,794,823.183,200,650,185.472,478,617,411.381,710,905,907.17
经营活动产生的现金流量净额171,674,399.62784,275,267.36481,960,456.57248,550,242.09
投资活动产生的现金流量:
投资活动现金流入小计2,175,436,429.616,975,028,763.324,942,143,757.753,156,092,918.68
投资活动现金流出小计2,430,086,326.096,939,049,472.744,610,620,481.382,626,039,316.1
投资活动产生的现金流量净额-254,649,896.4835,979,290.58331,523,276.37530,053,602.58
筹资活动产生的现金流量:
筹资活动现金流入小计2,000,000---
筹资活动现金流出小计241,788.6737,774,345.74737,269,148.6733,344,416.07
筹资活动产生的现金流量净额1,758,211.4-737,774,345.74-737,269,148.6-733,344,416.07
汇率变动对现金及现金等价物的影响-2,074,601.281,172,093.722,686,658.893,302,350.07
现金及现金等价物净增加额-83,291,886.7483,652,305.9278,901,243.2348,561,778.67
期末现金及现金等价物余额260,238,670.23343,707,442.68338,956,379.99308,616,915.43
补充资料:
现金及现金等价物的净增加额-83,652,305.92-48,561,778.67
最新报告期:2026-05-11
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
兴业证券孙媛媛,杨希成,黄翰漾2.182.502.882026-05-11
长城国瑞证券胡晨曦2.282.783.192026-04-30
东方证券伍云飞2.322.773.332026-04-29
西南证券杜向阳2.372.903.492026-04-23
国金证券甘坛焕,马居东2.402.853.452026-04-22
TOP↑